ProBiotix Health Statistics
Total Valuation
ProBiotix Health has a market cap or net worth of GBP 9.09 million. The enterprise value is 8.23 million.
Market Cap | 9.09M |
Enterprise Value | 8.23M |
Important Dates
The last earnings date was Friday, November 29, 2024.
Earnings Date | Nov 29, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
ProBiotix Health has 158.17 million shares outstanding. The number of shares has increased by 23.88% in one year.
Current Share Class | n/a |
Shares Outstanding | 158.17M |
Shares Change (YoY) | +23.88% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 4.28% |
Owned by Institutions (%) | n/a |
Float | 89.85M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 3.29 |
PB Ratio | 5.47 |
P/TBV Ratio | 9.05 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -16.59 |
EV / Sales | 3.87 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.06
Current Ratio | 3.06 |
Quick Ratio | 2.88 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -32.05% and return on invested capital (ROIC) is -20.92%.
Return on Equity (ROE) | -32.05% |
Return on Assets (ROA) | -14.88% |
Return on Capital (ROIC) | -20.92% |
Revenue Per Employee | 303,857 |
Profits Per Employee | -70,857 |
Employee Count | 7 |
Asset Turnover | 0.98 |
Inventory Turnover | 11.10 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -17.86% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -17.86% |
50-Day Moving Average | 6.03 |
200-Day Moving Average | 4.86 |
Relative Strength Index (RSI) | 44.35 |
Average Volume (20 Days) | n/a |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ProBiotix Health had revenue of GBP 2.13 million and -496,000 in losses. Loss per share was -0.00.
Revenue | 2.13M |
Gross Profit | 1.17M |
Operating Income | -518,000 |
Pretax Income | -518,000 |
Net Income | -496,000 |
EBITDA | -467,000 |
EBIT | -518,000 |
Loss Per Share | -0.00 |
Balance Sheet
Cash & Cash Equivalents | 865,000 |
Total Debt | n/a |
Net Cash | 865,000 |
Net Cash Per Share | 0.01 |
Equity (Book Value) | 1.28M |
Book Value Per Share | 0.01 |
Working Capital | 1.07M |
Cash Flow
Operating Cash Flow | -1.11M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 55.10%, with operating and profit margins of -24.35% and -23.32%.
Gross Margin | 55.10% |
Operating Margin | -24.35% |
Pretax Margin | -24.35% |
Profit Margin | -23.32% |
EBITDA Margin | -21.96% |
EBIT Margin | -24.35% |
FCF Margin | n/a |
Dividends & Yields
ProBiotix Health does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -23.88% |
Shareholder Yield | -23.88% |
Earnings Yield | n/a |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
ProBiotix Health has an Altman Z-Score of 7.7.
Altman Z-Score | 7.7 |
Piotroski F-Score | n/a |